Related references
Note: Only part of the references are listed.Targeting the Glucocorticoid Receptors During Alcohol Withdrawal to Reduce Protracted Neurocognitive Disorders
Daniel Beracochea et al.
FRONTIERS IN PSYCHIATRY (2019)
The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Louisa Degenhardt et al.
LANCET PSYCHIATRY (2018)
Alcohol withdrawal induces long-lasting spatial working memory impairments: relationship with changes in corticosterone response in the prefrontal cortex
Gaelle Dominguez et al.
ADDICTION BIOLOGY (2017)
Double-blind, 12 month follow-up, placebo-controlled trial of mifepristone on cognition in alcoholics: the MIFCOG trial protocol
Kim Donoghue et al.
BMC PSYCHIATRY (2016)
Acute oral administration of the novel, competitive and selective glucocorticoid receptor antagonist ORG 34517 reduces the severity of ethanol withdrawal and related hypothalamic-pituitary-adrenal axis activation
Anna R. Reynolds et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals
Leandro F. Vendruscolo et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Minimal clinically important difference on the Beck Depression Inventory - II according to the patient's perspective
K. S. Button et al.
PSYCHOLOGICAL MEDICINE (2015)
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III
Bridget F. Grant et al.
JAMA PSYCHIATRY (2015)
Widespread and sustained cognitive deficits in alcoholism: a meta-analysis
Katherine Stavro et al.
ADDICTION BIOLOGY (2013)
Mifepristone Pretreatment Reduces Ethanol Withdrawal Severity In Vivo
Lynda Sharrett-Field et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2013)
A Role for Cognitive Rehabilitation in Increasing the Effectiveness of Treatment for Alcohol Use Disorders
Marsha E. Bates et al.
NEUROPSYCHOLOGY REVIEW (2013)
A Randomized Trial to Examine the Effect of Mifepristone on Neuropsychological Performance and Mood in Patients with Bipolar Depression
Stuart Watson et al.
BIOLOGICAL PSYCHIATRY (2012)
The Importance of Glucocorticoids in Alcohol Dependence and Neurotoxicity
A. K. Rose et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2010)
Effects of the Glucocorticoid Antagonist, Mifepristone, on the Consequences of Withdrawal From Long Term Alcohol Consumption
Catherine Jacquot et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2008)
Neuropsychological and hypothalamic-pituitary-axis function in female patients with melancholic and non-melancholic depression
Ioannis Michopoulos et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2008)
Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression
Charles DeBattista et al.
BIOLOGICAL PSYCHIATRY (2006)
The neuropsychological profile of psychotic major depression and its relation to cortisol
Rowena G. Gomez et al.
BIOLOGICAL PSYCHIATRY (2006)
An 8-week open-label trial of a 6-day course of mifepristone for the treatment of psychotic depression
GM Simpson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Corticosterone increases damage and cytosolic calcium accumulation associated with ethanol withdrawal in rat hippocampal slice cultures
PJ Mulholland et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2005)
Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder
AH Young et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Impairment in cognitive functions after multiple detoxifications in alcoholic inpatients
T Duka et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2003)
Acute alcohol effects on cognitive function in social drinkers: their relationship to drinking habits
R Weissenborn et al.
PSYCHOPHARMACOLOGY (2003)
An open label trial of C-1073 (mifepristone) for psychotic major depression
JK Belanoff et al.
BIOLOGICAL PSYCHIATRY (2002)
Rapid reversal of psychotic depression using mifepristone
JK Belanoff et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Cognitive disturbance in outpatient depressed younger adults: Evidence of modest impairment
MM Grant et al.
BIOLOGICAL PSYCHIATRY (2001)
Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery
JA Sweeney et al.
BIOLOGICAL PSYCHIATRY (2000)
Group and case study of the dysexecutive syndrome in alcoholism without amnesia
H Ihara et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)
Pattern of motor and cognitive deficits in detoxified alcoholic men
EV Sullivan et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2000)
Share Paper
